Elutia Inc (ELUT)

Nov 21, 2024

ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024

Nov 20, 2024

Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St

Nov 20, 2024

Nov 19, 2024

Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 19, 2024

Nov 17, 2024

Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 17, 2024

Cantor Fitzgerald Reaffirms Overweight Rating for Elutia (NASDAQ:ELUT) - Defense World

Nov 17, 2024

Nov 15, 2024

Elutia's (ELUT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald - MarketBeat

Nov 15, 2024

Nov 15, 2024

Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

Elutia Inc. (ELUT) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch - TipRanks

Nov 15, 2024

Nov 14, 2024

Elutia Inc (ELUT) Q3 2024 Earnings: EPS of $0.03 Beats Estimates, Revenue of $5.92M Misses Expectations - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Elutia earnings beat by $0.11, revenue fell short of estimates - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025 - The Manila Times

Nov 14, 2024

Nov 13, 2024

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times

Nov 13, 2024

Nov 13, 2024

What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Elutia (ELUT) to Release Earnings on Thursday - Defense World

Nov 13, 2024

Nov 12, 2024

Elutia (ELUT) Set to Announce Earnings on Thursday - MarketBeat

Nov 12, 2024

Nov 01, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Rises By 7.4% - MarketBeat

Nov 01, 2024

Oct 30, 2024

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024 - The Manila Times

Oct 30, 2024

Oct 24, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - The Manila Times

Oct 24, 2024

Oct 22, 2024

Individual investors among Elutia Inc.'s (NASDAQ:ELUT) largest stockholders and were hit after last week's 10% price drop - Simply Wall St

Oct 22, 2024

Oct 17, 2024

Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution

Oct 17, 2024

Oct 15, 2024

SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc - GuruFocus.com

Oct 15, 2024

Oct 10, 2024

Preclinical Data Show Efficacy Of Elutia's Antibiotic-Eluting BioEnvelope - MPO-mag

Oct 10, 2024

Oct 10, 2024

Preclinical Data Show Efficacy of Elutia’s Antibiotic-Eluting BioEnvelope - MPO-mag

Oct 10, 2024

Oct 04, 2024

Elutia (NASDAQ:ELUT) vs. Curis (NASDAQ:CRIS) Head to Head Comparison - Defense World

Oct 04, 2024

Oct 01, 2024

Nantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT) - Defense World

Oct 01, 2024

Oct 01, 2024

Nantahala Capital Management LLC Purchases 145,697 Shares of Elutia Inc. (NASDAQ:ELUT) - MarketBeat

Oct 01, 2024

Sep 28, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1% - MarketBeat

Sep 28, 2024

Sep 18, 2024

Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World

Sep 18, 2024

Sep 18, 2024

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices - StockTitan

Sep 18, 2024

Sep 17, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9% - MarketBeat

Sep 17, 2024

Sep 12, 2024

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - HMP Global Learning Network

Sep 12, 2024

Sep 11, 2024

Elutia announces first patient implant of EluPro, the world’s first drug-eluting bioenvelope for cardiac pacemakers and neurostimulators - Cardiovascular Business

Sep 11, 2024

Sep 09, 2024

AIGH Capital Management LLC Increases Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat

Sep 09, 2024

Sep 08, 2024

Cantor Fitzgerald Reiterates “Overweight” Rating for Elutia (NASDAQ:ELUT) - Defense World

Sep 08, 2024

Sep 06, 2024

Elutia Celebrates First Year - ForexTV.com

Sep 06, 2024

Sep 06, 2024

Elutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 06, 2024

Sep 05, 2024

Elutia Announces First Patient Implant of EluPro™, the - GlobeNewswire

Sep 05, 2024

Sep 03, 2024

Elutia to Participate in Upcoming Investor Conferences - ForexTV.com

Sep 03, 2024

Aug 29, 2024

Ryan Marques Joins Elutia As VP Of Operations - MPO-mag

Aug 29, 2024

Aug 29, 2024

Short Interest in Elutia Inc. (NASDAQ:ELUT) Expands By 468.3% - Defense World

Aug 29, 2024

Aug 29, 2024

Ryan Marques Joins Elutia as VP of Operations - MPO-mag

Aug 29, 2024

Aug 27, 2024

Elutia Inc. (NASDAQ:ELUT) Short Interest Update - MarketBeat

Aug 27, 2024

Aug 21, 2024

Spine Implant Caused Patient's TB, Suit Says - Law360

Aug 21, 2024

Aug 19, 2024

ELUT (Elutia) Financial Strength : 2 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024

Aug 16, 2024

ELUT (Elutia) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Aug 10, 2024

Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 10, 2024

Aug 08, 2024

Elutia (NASDAQ:ELUT) Price Target Cut to $10.00 - MarketBeat

Aug 08, 2024

Aug 08, 2024

Elutia Wins FDA Clearance Of Its Antibiotic-Eluting BioEnvelope - MPO-mag

Aug 08, 2024